Brief: Centogene Sets Mission To Enable Cure Of 100 Rare Diseases Within Next 10 Years
June 22 (Reuters) - CENTOGENE NV 39K.MU :
* SETS MISSION TO ENABLE CURE OF 100 RARE DISEASES WITHIN
NEXT 10
YEARS
* MID-TERM TARGETS SET TO REACH 1 MILLION PATIENTS IN
BIO/DATABANK
AND 10 FULL DISEASE MODELS FOR RARE DISEASE RESEARCH AND
DEVELOPMENT PARTNERING
Source text for Eikon: ID:nEQ7jxVLla
Further company coverage: 39K.MU
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice